speb/financial-data huggingface dataset:
Stock screener scorecard for 4274.T (annual, report date 2026-03-31)
Altman Z-score: 3.3371539070411096 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 6.0152419215311355%
Capitalized R&D asset: 149585.1147107651
ROCI (R&D adjusted): 7.78404815115785%
Rosenberg metric: -3.7739264318250316
Free cash flow margin: 12.049616840040485%
Revenue growth: -1.890086601104348%
Rule of 40 score: 10.159530238936137
Market cap: 4314657280 (Mid Cap ($2B-$10B))
P/E ratio: 0.1575519181152984
Debt to equity: 0.1519
Free cash flow (dilution adjusted): 1611061.061061061
Operating income: 1895708.2082082082
Net income: 1334747.2472472473
Long score: 7 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for 4274.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 4314657280 (Mid Cap ($2B-$10B))
P/E ratio: 0.1575519181152984
Debt to equity: 0.1519
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 4662.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 25224683520 (Large Cap ($10B-$200B))
P/E ratio: 0.06305688999849725
Debt to equity: 0.14150000000000001
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 4967.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 404328546304 (Mega Cap (>= $200B))
P/E ratio: 0.7471056347460842
Debt to equity: 0.0034999999999999996
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 4979.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 25751685120 (Large Cap ($10B-$200B))
P/E ratio: 0.07694749639338835
Debt to equity: 0.4875
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 5943.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 106694131712 (Large Cap ($10B-$200B))
P/E ratio: 0.1929408959061311
Debt to equity: 0.0475
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 6357.T (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 41385111552 (Large Cap ($10B-$200B))
P/E ratio: 0.04845870678391532
Debt to equity: 0.3017
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 6923.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 422637666304 (Mega Cap (>= $200B))
P/E ratio: 0.0744315119497176
Debt to equity: 0.2114
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 7480.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 30864250880 (Large Cap ($10B-$200B))
P/E ratio: 0.08283477275725337
Debt to equity: 0.07519999999999999
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 7779.T (annual, report date 2026-03-31)
Altman Z-score: 3.3515462505631892 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 1.997188552635069%
Capitalized R&D asset: 12936391.812555138
ROCI (R&D adjusted): -1.2444661312305574%
Rosenberg metric: -0.23739126450394063
Free cash flow margin: 4.6021840873634945%
Revenue growth: -17.88113957936038%
Rule of 40 score: -13.278955491996886
Market cap: 46659952640 (Large Cap ($10B-$200B))
P/E ratio: 2.2539662950621855
Debt to equity: 0.0118
Free cash flow (dilution adjusted): 1107357.3573573574
Operating income: -3760010.01001001
Net income: 957207.2072072072
Long score: 7 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 7779.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 46659952640 (Large Cap ($10B-$200B))
P/E ratio: 2.2539662950621855
Debt to equity: 0.0118
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 8512.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 344437504 (Small Cap ($300M-$2B))
P/E ratio: 0.3972890862351017
Debt to equity: 0.016399999999999998
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 8512.HK (annual, report date 2025-12-31)
Altman Z-score: 5.188594675992502 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 9.215613968986903%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 17.14798830535199%
Free cash flow margin: 15.67918334988665%
Revenue growth: -1.500882504181095%
Rule of 40 score: 14.178300845705554
Market cap: 344437504 (Small Cap ($300M-$2B))
P/E ratio: 0.3972890862351017
Debt to equity: 0.016399999999999998
Free cash flow (dilution adjusted): 18099742.93059126
Operating income: 16593059.12596401
Net income: 13041773.778920308
Long score: 7 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for 9158.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 22719363072 (Large Cap ($10B-$200B))
P/E ratio: 0.0559810889582823
Debt to equity: 1.5434
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 9218.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 7775354880 (Mid Cap ($2B-$10B))
P/E ratio: 0.19401657046764842
Debt to equity: 2.0138
Long score: 0 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 9242.T (quarterly, report date 2026-01-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 2488957184 (Mid Cap ($2B-$10B))
P/E ratio: 0.07353838698432817
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 9696.HK (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 56433410048 (Large Cap ($10B-$200B))
P/E ratio: 3.8298652794451113
Debt to equity: 0.2554
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ACRE (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -1.9085411175058589%
Capitalized R&D asset: 0
Free cash flow margin: -573.50790513834%
Revenue growth: -36.63911845730027%
Rule of 40 score: -610.1470235956402
Market cap: 252439072 (Micro Cap ($50M-$300M))
Debt to equity: 2.5824000000000003
Free cash flow (dilution adjusted): -58039000
Net income: -9605000
Long score: 0 | Short score: 9
Recommendation: Short
Stock screener scorecard for AELIS.PA (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 14316734 (Nano Cap (< $50M))
Debt to equity: 1.4880000000000002
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for AELIS.PA (annual, report date 2025-12-31)
Altman Z-score: 0.23691630877811765 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -138.36196752176983%
Capitalized R&D asset: 19668969.852941178
ROCI (R&D adjusted): -39.319116699624935%
Revenue growth: -100%
Rule of 40 score: -100
Market cap: 14316734 (Nano Cap (< $50M))
Debt to equity: 1.4880000000000002
Free cash flow (dilution adjusted): -7020000
Operating income: -7291764.705882353
Net income: -7569411.764705882
Long score: 0 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for C5H.IR (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1537374848 (Small Cap ($300M-$2B))
P/E ratio: 11.372549019607844
Debt to equity: 0.2772
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for CIG.C (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Revenue growth: -1.6310968843556626%
Rule of 40 score: -1.6310968843556626
Market cap: 9240002560 (Mid Cap ($2B-$10B))
P/E ratio: 9.38235294117647
Debt to equity: 0.6926000000000001
Operating income: 23202043677.688213
Net income: 186121673.0038023
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for DEM.AX (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 31710508 (Nano Cap (< $50M))
Debt to equity: 0.12869999999999998
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for DEM.AX (annual, report date 2025-12-31)
Altman Z-score: 1.914580159354987 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -10.260489162855437%
Free cash flow margin: 0.023419203747072598%
Revenue growth: 29.718243722980375%
Rule of 40 score: 29.741662926727447
Market cap: 31710508 (Nano Cap (< $50M))
Debt to equity: 0.12869999999999998
Free cash flow (dilution adjusted): 4697.986577181208
Operating income: -1038926.1744966443
Net income: -1359731.543624161
Long score: 5 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for DMCU.V (quarterly, report date 2026-03-31)
Altman Z-score: 9.987541168710088 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -22.575975464861152%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -22.612573910738153%
Rule of 40 score: 0
Market cap: 15821495 (Nano Cap (< $50M))
Debt to equity: 0.018600000000000002
Free cash flow (dilution adjusted): -855267.6258992807
Operating income: -835761.8705035972
Net income: -846260.4316546763
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for EAM.OL (quarterly, report date 2026-03-31)
Altman Z-score: 4.29101664630553 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 61.82043062854143%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -1.526828941000466%
Free cash flow margin: 191.85908509790085%
Revenue growth: -4.162375638773203%
Rule of 40 score: 187.69670945912765
Market cap: 61090960 (Micro Cap ($50M-$300M))
P/E ratio: 80.61258518042841
Debt to equity: 0.7314
Free cash flow (dilution adjusted): 43031.44912641315
Operating income: -18873.895169578624
Net income: 202680.2672147996
Long score: 7 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for EDPR.LS (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 14570860544 (Large Cap ($10B-$200B))
P/E ratio: 66.89075630252101
Debt to equity: 0.8278
Long score: 1 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for EDPR.LS (annual, report date 2025-12-31)
Altman Z-score: 0.7748981527086899 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -18.385306515309814%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.4579572132077048%
Free cash flow margin: -65.4696449728544%
Revenue growth: 31.344563194445474%
Rule of 40 score: -34.125081778408926
Market cap: 14570860544 (Large Cap ($10B-$200B))
P/E ratio: 66.89075630252101
Debt to equity: 0.8278
Free cash flow (dilution adjusted): -2073151764.7058823
Operating income: 1060098823.5294118
Net income: 362072941.1764706
Long score: 2 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for EFR.TO (quarterly, report date 2026-03-31)
Altman Z-score: 3.566538708489986 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -2.953207955523842%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -1.0224431364857902%
Free cash flow margin: -19.54629164573916%
Revenue growth: 32.23378348461368%
Rule of 40 score: 12.687491838874521
Market cap: 3983711232 (Mid Cap ($2B-$10B))
Debt to equity: 0.9315000000000001
Free cash flow (dilution adjusted): -7005000
Operating income: -14545000
Net income: -10844000
Long score: 5 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for EHL.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 497639744 (Small Cap ($300M-$2B))
P/E ratio: 3.6165577342047928
Debt to equity: 0.4163
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ELAB (quarterly, report date 2026-03-31)
Altman Z-score: -1.3747314564333362 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -74.21378415829842%
Capitalized R&D asset: 74055.34
ROCI (R&D adjusted): -22.314185088948516%
Rosenberg metric: 3.7441492918363624
Free cash flow margin: -491.33834022000195%
Revenue growth: 124.23981376752506%
Rule of 40 score: -367.0985264524769
Market cap: 4089375 (Nano Cap (< $50M))
Debt to equity: 0.6312
Free cash flow (dilution adjusted): -3350898
Operating income: -3320057
Net income: -4967259
Long score: 1 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for EZE.MC (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 50855172 (Micro Cap ($50M-$300M))
Debt to equity: 1.8428
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for EZE.MC (annual, report date 2025-12-31)
Altman Z-score: 1.5090296324710297 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -2.635658914728682%
Free cash flow margin: -25.26223776223776%
Revenue growth: 179.1804362194316%
Rule of 40 score: 153.91819845719385
Market cap: 50855172 (Micro Cap ($50M-$300M))
Debt to equity: 1.8428
Free cash flow (dilution adjusted): -10200000
Operating income: -560000
Net income: -3125882.3529411764
Long score: 0 | Short score: 9
Recommendation: Short
Stock screener scorecard for FCHL (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1503365 (Nano Cap (< $50M))
Debt to equity: 0.8009999999999999
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for FCHL (annual, report date 2025-12-31)
Altman Z-score: 0.0033669095051218623 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -181.75287356321837%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -118.23681936041486%
Free cash flow margin: 14.024096385542167%
Revenue growth: 4.586693548387097%
Rule of 40 score: 18.610789933929265
Market cap: 1503365 (Nano Cap (< $50M))
Debt to equity: 0.8009999999999999
Free cash flow (dilution adjusted): 454687.5
Operating income: -1068750
Net income: -1066406.25
Long score: 3 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for FF (quarterly, report date 2026-03-31)
Altman Z-score: 3.0591332690002524 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -12.700190943231378%
Capitalized R&D asset: 1582440
ROCI (R&D adjusted): -12.75776550838073%
Rosenberg metric: -9.59825327510917
Free cash flow margin: -80.39559339008512%
Revenue growth: 61.032154016732186%
Rule of 40 score: -19.36343937335294
Market cap: 203965312 (Micro Cap ($50M-$300M))
Debt to equity: 0
Free cash flow (dilution adjusted): -25688000
Operating income: -20843000
Net income: -20582000
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for GNM.AX (annual, report date 2025-06-30)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -45.13263267893367%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -83.84273981970274%
Rule of 40 score: 0
Market cap: 21225390 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -486484.3137254902
Operating income: -740453.5947712418
Net income: -402313.07189542486
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for GNM.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 21225390 (Nano Cap (< $50M))
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for HHS (quarterly, report date 2026-03-31)
Altman Z-score: 13.334031446437322 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -1.0187838268067495%
Free cash flow margin: -3.059252898239588%
Revenue growth: -6.50810376837774%
Rule of 40 score: -9.567356666617329
Market cap: 17732534 (Nano Cap (< $50M))
Debt to equity: 1.0951
Free cash flow (dilution adjusted): -1140000
Operating income: -608000
Net income: -628000
Long score: 2 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for HPF (quarterly, report date 2026-01-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 341217056 (Small Cap ($300M-$2B))
P/E ratio: 11.938461538461537
Debt to equity: 0.5984
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for HTLD (quarterly, report date 2026-03-31)
Altman Z-score: 2.8249617394437747 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.9933009284349706%
Free cash flow margin: 2.8220315904139435%
Revenue growth: -1.7278581584009367%
Rule of 40 score: 1.0941734320130068
Market cap: 1106552832 (Small Cap ($300M-$2B))
Debt to equity: 0.2045
Free cash flow (dilution adjusted): 4974000
Operating income: -10612000
Net income: -4821000
Long score: 7 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for IBAB.BR (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 483229120 (Small Cap ($300M-$2B))
P/E ratio: 35.65826330532213
Debt to equity: 0.9192
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ILT.AX (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 32686998 (Nano Cap (< $50M))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for MIN (quarterly, report date 2026-04-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 273115776 (Micro Cap ($50M-$300M))
P/E ratio: 24.5
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for MRX (quarterly, report date 2026-03-31)
Altman Z-score: 0.25877636383031577 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 12.20375651489822%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 9.659969088098924%
Revenue growth: -40.38430864561533%
Rule of 40 score: -40.38430864561533
Market cap: 4715787776 (Mid Cap ($2B-$10B))
P/E ratio: 10.079365079365079
Debt to equity: 9.7413
Operating income: 476973684.2105263
Net income: 147894736.84210527
Long score: 1 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for NMCO (annual, report date 2025-10-31)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 0.18830745432155666%
Capitalized R&D asset: 0
Free cash flow margin: 1755.2172869810424%
Revenue growth: -97.82438099917336%
Rule of 40 score: 1657.392905981869
Market cap: 579372352 (Small Cap ($300M-$2B))
P/E ratio: 21.183673469387756
Debt to equity: 0.017263729944853572
Free cash flow (dilution adjusted): 49596543
Net income: 1134400
Long score: 4 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for NMCO (quarterly, report date 2025-10-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 579372352 (Small Cap ($300M-$2B))
P/E ratio: 21.183673469387756
Debt to equity: 0.017263729944853572
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ONL (quarterly, report date 2026-03-31)
Altman Z-score: -0.4992528511158238 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -3.2693906527012713%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.3287355245131904%
Free cash flow margin: -70.05045353036861%
Revenue growth: 2.987024049518726%
Rule of 40 score: -67.06342948084989
Market cap: 147758176 (Micro Cap ($50M-$300M))
Debt to equity: 0.8299
Free cash flow (dilution adjusted): -25408000
Operating income: 3369000
Net income: -13568000
Long score: 1 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for OPTG.V (quarterly, report date 2025-06-30)
Altman Z-score: -9.56840736702127 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -26.92492396350248%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -17.696814470946048%
Rule of 40 score: 0
Market cap: 1342492 (Nano Cap (< $50M))
Debt to equity: 0.8033
Free cash flow (dilution adjusted): 48248.17518248175
Operating income: -40347.44525547445
Net income: -61486.861313868605
Long score: 4 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for ORI (quarterly, report date 2026-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 10299900928 (Large Cap ($10B-$200B))
P/E ratio: 8.973684210526317
Debt to equity: 0.37520000000000003
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for PMI (quarterly, report date 2026-03-31)
Altman Z-score: -11.672228775552474 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 2575320
ROCI (R&D adjusted): -329.7486623486342%
Rosenberg metric: -0.24862888482632542
Free cash flow margin: -347.04347826086956%
Revenue growth: 13.974231912784935%
Rule of 40 score: -333.0692463480846
Market cap: 9025843 (Nano Cap (< $50M))
Debt to equity: -2.2610497237569063
Free cash flow (dilution adjusted): -3991000
Operating income: -4511000
Net income: -7616000
Long score: 1 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for QUBT (quarterly, report date 2026-03-31)
Altman Z-score: 43.560005166006206 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -0.24799473552583967%
Capitalized R&D asset: 13149650
ROCI (R&D adjusted): -1.219668921617753%
Rosenberg metric: -0.08894917190177042
Free cash flow margin: -338.4177729612571%
Revenue growth: 1764.141414141414%
Rule of 40 score: 1425.7236411801568
Market cap: 1675724928 (Small Cap ($300M-$2B))
Debt to equity: 0.0034000000000000002
Free cash flow (dilution adjusted): -12491000
Operating income: -20550000
Net income: -4050000
Long score: 6 | Short score: 13
Recommendation: Short
Stock screener scorecard for RHLD (quarterly, report date 2026-03-31)
Altman Z-score: 0.3494448974515649 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -2.450546842979485%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.12441347931181573%
Free cash flow margin: -32.07454634624816%
Revenue growth: 246.44759534105293%
Rule of 40 score: 214.37304899480478
Market cap: 1087339904 (Small Cap ($300M-$2B))
P/E ratio: 23.555878084179973
Debt to equity: 0.7211
Free cash flow (dilution adjusted): -130800000
Operating income: -7000000
Net income: 61500000
Long score: 1 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for ROSSELLIND.NS (quarterly, report date 2026-03-31)
Altman Z-score: 1.158315248608462 (Distress Zone)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -11.337777555009772%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -10.797632938823137%
Revenue growth: -83.46489102340715%
Rule of 40 score: -83.46489102340715
Market cap: 2221830144 (Mid Cap ($2B-$10B))
P/E ratio: 0.1067354879583624
Debt to equity: 0.32355444305381725
Operating income: -2745866.8927511657
Net income: -2521195.4217888936
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for ROSSELLIND.NS (annual, report date 2026-03-31)
Altman Z-score: 2.3696381185636186 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 4.220339832589845%
Capitalized R&D asset: 72739.29727785106
ROCI (R&D adjusted): 7.914808412970433%
Free cash flow margin: 6.824051837419004%
Revenue growth: 12.806149552553725%
Rule of 40 score: 19.63020138997273
Market cap: 2221830144 (Mid Cap ($2B-$10B))
P/E ratio: 0.1067354879583624
Debt to equity: 0.32355444305381725
Free cash flow (dilution adjusted): 1596015.260703688
Operating income: 2091988.1305637981
Net income: 1680796.9478592623
Long score: 7 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for RRI.V (quarterly, report date 2026-03-31)
Altman Z-score: 8.585092009562757 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -2.305361343234407%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -2.1864610250334713%
Rule of 40 score: 0
Market cap: 40180692 (Nano Cap (< $50M))
P/E ratio: 7.913669064748202
Debt to equity: 0
Free cash flow (dilution adjusted): -295855.39568345324
Operating income: -187819.42446043168
Net income: 38125.89928057554
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for RVRG.L (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 4338718 (Nano Cap (< $50M))
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for SAFT (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -1.7781281583827155%
Capitalized R&D asset: 0
Free cash flow margin: -6.528901446116955%
Revenue growth: -1.3276455383053964%
Rule of 40 score: -7.856546984422351
Market cap: 1515330304 (Small Cap ($300M-$2B))
P/E ratio: 16.947990543735223
Debt to equity: 0.07139999999999999
Free cash flow (dilution adjusted): -20312000
Net income: -14323000
Long score: 2 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for SBX.DE (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 8913020 (Nano Cap (< $50M))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for SRG.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 2142945408 (Mid Cap ($2B-$10B))
P/E ratio: 12.200435729847493
Debt to equity: 0.4144
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for SZ50.DE (annual, report date 2025-12-31)
Altman Z-score: 0.28894707696624417 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 0.5129360531349719%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.5766627148334216%
Revenue growth: -31.609957419582773%
Rule of 40 score: -31.609957419582773
Market cap: 10617750 (Nano Cap (< $50M))
P/E ratio: 144.11764705882354
Debt to equity: 0
Operating income: 170468.2588235294
Net income: 107055.92941176471
Long score: 2 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for SZ50.DE (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 10617750 (Nano Cap (< $50M))
P/E ratio: 144.11764705882354
Debt to equity: 0
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for TAND.L (annual, report date 2025-12-31)
Altman Z-score: 35.54583889537596 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -67.80957593884163%
Capitalized R&D asset: 95186.14059613411
ROCI (R&D adjusted): -70.12066753411592%
Rosenberg metric: 1.6573337712445526
Free cash flow margin: -137.50269992538387%
Revenue growth: 8.724380400833176%
Rule of 40 score: -128.77831952455068
Market cap: 21234902 (Nano Cap (< $50M))
Debt to equity: 0.0195
Free cash flow (dilution adjusted): -2271128.378378378
Operating income: -2252241.891891892
Net income: -2134258.108108108
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for TAND.L (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 21234902 (Nano Cap (< $50M))
Debt to equity: 0.0195
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for TRVG (quarterly, report date 2026-03-31)
Altman Z-score: -0.97222501901018 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -4.827381296270314%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -3.922822768617417%
Free cash flow margin: -5.1556059429083305%
Revenue growth: 16.378879166618738%
Rule of 40 score: 11.223273223710407
Market cap: 386027840 (Small Cap ($300M-$2B))
P/E ratio: 15.941176470588234
Debt to equity: 0.17149999999999999
Free cash flow (dilution adjusted): -8467816.091954023
Operating income: -11490804.597701149
Net income: -8379310.344827586
Long score: 2 | Short score: 12
Recommendation: Short
Stock screener scorecard for TTGI.V (quarterly, report date 2026-03-31)
Altman Z-score: -4.332934517397955 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 868717.1227222602
ROCI (R&D adjusted): -73.99546929918674%
Rosenberg metric: 1.8479389418413994
Free cash flow margin: -24.975874935167276%
Revenue growth: 321.03211466641113%
Rule of 40 score: 296.05623973124386
Market cap: 11205186 (Nano Cap (< $50M))
Debt to equity: -1.4569591633931134
Free cash flow (dilution adjusted): -1157785.6115107914
Operating income: -1924597.1223021585
Net income: -1886989.9280575542
Long score: 4 | Short score: 11
Recommendation: Short
Stock screener scorecard for UDR (quarterly, report date 2026-03-31)
Altman Z-score: 0.874052644896878 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 9.819885077061674%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.7994452452974079%
Free cash flow margin: 17.45172584648549%
Revenue growth: -1.6755713381943451%
Rule of 40 score: 15.776154508291146
Market cap: 14668715008 (Large Cap ($10B-$200B))
P/E ratio: 22.693877551020407
Debt to equity: 1.4237
Free cash flow (dilution adjusted): 74318000
Operating income: 78118000
Net income: 202904000
Long score: 3 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for VBIO (quarterly, report date 2026-03-31)
Altman Z-score: -2.4386403495403433 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -112.4207385303991%
Capitalized R&D asset: 2996750
ROCI (R&D adjusted): -13.243774842873213%
Rule of 40 score: 0
Market cap: 950644 (Nano Cap (< $50M))
Debt to equity: 1.5399
Free cash flow (dilution adjusted): -5226000
Operating income: -5634000
Net income: -6202000
Long score: 0 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for VIVIDHA.NS (annual, report date 2026-03-31)
Altman Z-score: 1.5724341992007205 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -20.289928962305837%
Free cash flow margin: 151.64930555555557%
Rule of 40 score: 151.64930555555557
Market cap: 155131280 (Micro Cap ($50M-$300M))
Debt to equity: -15.450392927308465
Free cash flow (dilution adjusted): 18514.20093259856
Operating income: -126526.07036880034
Net income: -162908.01186943622
Long score: 3 | Short score: 8
Recommendation: Short
Stock screener scorecard for VIVIDHA.NS (quarterly, report date 2026-03-31)
Altman Z-score: 2.0473580367874957 (Grey Zone)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -5.004928452465926%
Revenue growth: -100%
Rule of 40 score: -100
Market cap: 155131280 (Micro Cap ($50M-$300M))
Debt to equity: -15.450392927308465
Operating income: -31210.258584145824
Net income: -44902.501059771086
Long score: 2 | Short score: 8
Recommendation: Short
Stock screener scorecard for VODI.DE (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 30891468800 (Large Cap ($10B-$200B))
Debt to equity: 1.0015
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for WISE.L (annual, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 8502069760 (Mid Cap ($2B-$10B))
P/E ratio: 0.33004385964912275
Debt to equity: 0.25129999999999997
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for XLS.SW (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 95164936 (Micro Cap ($50M-$300M))
Debt to equity: 0.16269999999999998
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for XLS.SW (annual, report date 2025-12-31)
Altman Z-score: 0.10422267759573128 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 110169.87857142858
ROCI (R&D adjusted): -6.299271109602987%
Rosenberg metric: -34.59177601136226
Free cash flow margin: -463.1837218002783%
Revenue growth: -62.431864631677804%
Rule of 40 score: -525.6155864319561
Market cap: 95164936 (Micro Cap ($50M-$300M))
Debt to equity: 0.16269999999999998
Free cash flow (dilution adjusted): -1614183.5443037974
Operating income: -39944787.34177215
Net income: -27275078.481012657
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for XNCR (quarterly, report date 2026-03-31)
Altman Z-score: 2.4761958422355366 (Grey Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -24.9904041288819%
Capitalized R&D asset: 126042190
ROCI (R&D adjusted): -9.434598937833538%
Free cash flow margin: -1722.7413640389723%
Revenue growth: -84.00679958919149%
Rule of 40 score: -1806.7481636281639
Market cap: 1441312768 (Small Cap ($300M-$2B))
Debt to equity: 0.3397
Free cash flow (dilution adjusted): -77799000
Operating income: -77862000
Net income: -128916000
Long score: 3 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for YRD (quarterly, report date 2026-03-31)
Altman Z-score: 1.3123956446481175 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -5.630357093557923%
Capitalized R&D asset: 31626352.373279005
ROCI (R&D adjusted): -3.1571020783267927%
Rosenberg metric: 0.8000681975749973
Free cash flow margin: -70.6728271157499%
Revenue growth: -41.83881733160943%
Rule of 40 score: -112.51164444735932
Market cap: 103236384 (Micro Cap ($50M-$300M))
Debt to equity: 0.004
Free cash flow (dilution adjusted): -94875253.2561505
Operating income: -53771780.02894356
Net income: -71424167.87264833
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for YTY.V (quarterly, report date 2026-03-31)
Altman Z-score: -3.7387519930987616 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 142670
ROCI (R&D adjusted): 0.2092646203440406%
Rosenberg metric: 3.2777777777777777
Free cash flow margin: 5.446378439079169%
Revenue growth: 6.902761104441776%
Rule of 40 score: 12.349139543520945
Market cap: 9911651 (Nano Cap (< $50M))
Debt to equity: 1.9265
Free cash flow (dilution adjusted): 97000
Operating income: 15000
Net income: -60000
Long score: 6 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for 9218.T (annual, report date 2025-12-31)
Altman Z-score: 3.2016435089903514 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -37.28636623986106%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 15.48222949938009%
Free cash flow margin: 7.778320439210791%
Revenue growth: 25.793722678819442%
Rule of 40 score: 33.57204311803024
Market cap: 8638024241.158901 (Mid Cap ($2B-$10B))
P/E ratio: 33.8877612922621
Debt to equity: 1.6717832081008426
Free cash flow (dilution adjusted): 3200326.066108305
Operating income: 3828246.275813567
Net income: 1629697.5896681799
Long score: 6 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 9242.T (annual, report date 2025-07-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1643697437.9999998 (Small Cap ($300M-$2B))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 9696.HK (annual, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 5413381.359458991
Rule of 40 score: 0
Market cap: 10910348796.156813 (Large Cap ($10B-$200B))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ACRE (annual, report date 2025-12-31)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Free cash flow margin: 68.93711596287096%
Rule of 40 score: 68.93711596287096
Market cap: 248555386.24 (Micro Cap ($50M-$300M))
Debt to equity: 2.055578450766139
Free cash flow (dilution adjusted): 15819000
Net income: -902000
Long score: 3 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for CIG.C (annual, report date 2025-12-31)
Altman Z-score: 1.2933472868613174 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 58.091534549805566%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 12.038199596697483%
Free cash flow margin: 5.752373645343819%
Revenue growth: 18.71697181619544%
Rule of 40 score: 24.46934546153926
Market cap: 13053022594.8108 (Large Cap ($10B-$200B))
P/E ratio: 2.664425922598653
Debt to equity: 0.6956719498967845
Free cash flow (dilution adjusted): 547262773.7226276
Operating income: 1154744525.547445
Net income: 893978102.189781
Long score: 5 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for DMCU.V (annual, report date 2025-12-31)
Altman Z-score: 11.683110225186661 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -69.5702364394993%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -70.09036254206276%
Rule of 40 score: 0
Market cap: 23013084.480000004 (Nano Cap (< $50M))
Debt to equity: 0.025035072866904515
Free cash flow (dilution adjusted): -2062375.912408759
Operating income: -1700840.8759124086
Net income: -1704364.9635036495
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for EAM.OL (annual, report date 2025-12-31)
Altman Z-score: 3.6362157884706705 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -46.7182307906255%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -4.331714230440841%
Free cash flow margin: -106.36802014210424%
Revenue growth: -8.837814064552525%
Rule of 40 score: -115.20583420665676
Market cap: 52256999.79472112 (Micro Cap ($50M-$300M))
Debt to equity: 2.2477739348002053
Free cash flow (dilution adjusted): -128969.05472636815
Operating income: -43757.31343283582
Net income: -113546.16915422885
Long score: 2 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for EFR.TO (annual, report date 2025-12-31)
Altman Z-score: 3.0966558515377405 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -19.582872182280525%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -7.326786028585729%
Free cash flow margin: -233.40766360243924%
Revenue growth: -15.607957600430142%
Rule of 40 score: -249.0156212028694
Market cap: 3626563958.014598 (Mid Cap ($2B-$10B))
Debt to equity: 0.9899175176172407
Free cash flow (dilution adjusted): -153867000
Operating income: -101155000
Net income: -85634000
Long score: 3 | Short score: 9
Recommendation: Short
Stock screener scorecard for ELAB (annual, report date 2025-12-31)
Altman Z-score: 15.530688933114256 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -204.00845333637832%
Capitalized R&D asset: 219573.47999999998
ROCI (R&D adjusted): -73.92152251238763%
Rosenberg metric: 1.770730215758595
Free cash flow margin: -1078.316985378353%
Rule of 40 score: -1078.316985378353
Market cap: 161394035.52 (Micro Cap ($50M-$300M))
Debt to equity: 0.3374794988415745
Free cash flow (dilution adjusted): -6362976
Operating income: -6821330
Net income: -7747813
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for FF (annual, report date 2025-12-31)
Altman Z-score: 1.9495533624272885 (Grey Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -25.70907774646431%
Capitalized R&D asset: 7992650
ROCI (R&D adjusted): -29.156197411140667%
Rosenberg metric: -14.793137991485098
Free cash flow margin: -49.07981867936746%
Revenue growth: -60.65488885875261%
Rule of 40 score: -109.73470753812006
Market cap: 137731411.98000002 (Micro Cap ($50M-$300M))
Debt to equity: 0
Free cash flow (dilution adjusted): -46990000
Operating income: -52990000
Net income: -49397000
Long score: 3 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for HHS (annual, report date 2025-12-31)
Altman Z-score: 14.622240523185567 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.5159417469430116%
Free cash flow margin: -2.9767500156671054%
Revenue growth: -13.85862817287656%
Rule of 40 score: -16.835378188543665
Market cap: 22332604.7 (Nano Cap (< $50M))
Debt to equity: 1.0914937152879276
Free cash flow (dilution adjusted): -4750000
Operating income: 2168000
Net income: -811000
Long score: 2 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for HPF (annual, report date 2025-07-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 319133219.46 (Small Cap ($300M-$2B))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for HTLD (annual, report date 2025-12-31)
Altman Z-score: 2.6025923078102653 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -5.7207294260592%
Free cash flow margin: -8.565127111649492%
Revenue growth: -23.08348074626424%
Rule of 40 score: -31.64860785791373
Market cap: 697407264 (Small Cap ($300M-$2B))
Debt to equity: 0.21371102805569567
Free cash flow (dilution adjusted): -69010000
Operating income: -61867000
Net income: -52453000
Long score: 3 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for MIN (annual, report date 2025-10-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 5.864127817139689%
Capitalized R&D asset: 0
Revenue growth: -32.51486978445449%
Rule of 40 score: -32.51486978445449
Market cap: 279943665.48 (Micro Cap ($50M-$300M))
P/E ratio: 15.347178660935901
Debt to equity: 0
Net income: 18240725
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for MRX (annual, report date 2025-12-31)
Altman Z-score: 0.3867884703615735 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 35.62042223179664%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 31.55158013848105%
Free cash flow margin: 16.645545209102426%
Revenue growth: 35.55714066975641%
Rule of 40 score: 52.20268587885883
Market cap: 2027486660.342 (Mid Cap ($2B-$10B))
P/E ratio: 6.589166916938577
Debt to equity: 8.099873377651164
Free cash flow (dilution adjusted): 816486486.4864864
Operating income: 1582567567.5675676
Net income: 415810810.8108108
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for ONL (annual, report date 2025-12-31)
Altman Z-score: -0.3961542034255376 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -24.162290367024443%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.20885664006942603%
Free cash flow margin: -21.681442900973266%
Revenue growth: -10.442066698208198%
Rule of 40 score: -32.12350959918146
Market cap: 126162750.96000001 (Micro Cap ($50M-$300M))
Debt to equity: 0.742907696372385
Free cash flow (dilution adjusted): -32012000
Operating income: -2166000
Net income: -139286000
Long score: 1 | Short score: 9
Recommendation: Short
Stock screener scorecard for OPTG.V (annual, report date 2024-09-30)
Altman Z-score: -8.909857266744527 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -53.04309316654996%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -47.24196699505341%
Rule of 40 score: 0
Market cap: 1952715.68 (Nano Cap (< $50M))
Debt to equity: 0.35334190272461874
Free cash flow (dilution adjusted): -133142.22222222222
Operating income: -218881.48148148146
Net income: -246438.5185185185
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for ORI (annual, report date 2025-12-31)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 15.92715343772194%
Capitalized R&D asset: 0
Free cash flow margin: 12.744089316987742%
Revenue growth: 10.986928422177948%
Rule of 40 score: 23.73101773916569
Market cap: 10338869167.800001 (Large Cap ($10B-$200B))
P/E ratio: 10.976610221679586
Debt to equity: 0.2681758375223508
Free cash flow (dilution adjusted): 1164300000
Net income: 941900000
Long score: 7 | Short score: 0
Recommendation: Neutral